![Invitae-ArcherDX Merger to Create Precision Oncology Powerhouse](https://www.g2intelligence.com/wp-content/uploads/2023/04/56181_G2_stock_7-1080x675.jpg)
Invitae-ArcherDX Merger to Create Precision Oncology Powerhouse
...
...
...
...
...
PAMA price cuts were supposed to drive consolidation in the lab market. The expectation was that price pressures would make it impossible for smaller labs to remain independent, rendering them juicy targets for the likes of